Androtriol injection for moderate to severe ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new medicine called Androtriol for people who have had a moderate to severe stroke caused by a blood clot. It is added to the standard procedure to remove the clot, and aims to reduce brain damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Before this stroke, you could do your daily activities without help (mRS score 0 or 1).
- You are planning to have or have already had a procedure to remove the blood clot from your brain within 24 hours of your stroke starting.
- You can get the first dose of the study medicine within 24 hours of your stroke starting.
- Your stroke symptoms are moderate to severe (NIHSS score 6 or higher) before the clot removal procedure.
- You do not have bleeding in the brain or other conditions listed in the exclusion criteria (like severe kidney or liver disease, recent surgery, or pregnancy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, QHRD106, given as an injection for people who have had a moderate-to-severe acute ischemic stroke. It aims to see if the drug can help recovery when given within 24 hours after the stroke starts, and it is for patients who are not receiving standard clot-busting treatment.
This trial tests whether adding a second medicine (tirofiban) to standard clot-busting treatment can help people who are not improving after the first hour. It is for people with a moderate to severe stroke who are not candidates for a clot-removal procedure.
This trial tests whether injecting a blood thinner called tirofiban directly into brain blood vessels during a stroke procedure helps prevent clots from forming again. If you've had a stroke caused by a large clot in your brain that was successfully removed, this study may help protect your recovery.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
This trial tests whether high-dose atorvastatin can help protect the artery wall after emergency clot-removal treatment for an acute stroke. It uses a special 3T MRI scan to look for changes in the blood vessels and may lower the risk of future problems if the artery wall is better protected.
This trial tests if a medication called tirofiban can help people who had a stroke 4.5 to 24 hours ago and received clot-dissolving treatment (IVT). If you have had a stroke and your symptoms did not improve or got worse after IVT, this study might offer a way to prevent further disability.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.